Recently, hydrazide derivative was reported as a potent and selective inhibitor for antibacterial–antifungal (Somashekhar, 2013; Popiołek, 2017), anti-inflammatory (Todeschini et al., 1998), antimalarial (Melnyk et al., 2006), and anti-tuberculosis activities (Bedia et al., 2006), as an Entamoeba histolyica (Afreen et al., 2016), a cruzipain inhibitor (Cerecetto and Gonzalez, 2010) and as Epidermal growth factor receptor (EGFR) Kinase Inhibitor (Wang et al., 2016). Here, EGFR is linked to tuberculosis.